ZWJ Investment Counsel’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,433
Closed -$457K 167
2017
Q4
$457K Buy
1,433
+131
+10% +$42K 0.04% 172
2017
Q3
$408K Sell
1,302
-259
-17% -$76.7K 0.03% 178
2017
Q2
$424K Sell
1,561
-173
-10% -$45.7K 0.03% 180
2017
Q1
$474K Buy
+1,734
New +$490K 0.04% 175

Other funds holding BIIB

ZWJ Investment Counsel's BIIB Position: Q1 2018 in Review

ZWJ Investment Counsel sold out of Biogen (BIIB) in Q1 2018, closing a stake of 1,433 shares — an estimated $457K sold.

ZWJ Investment Counsel first reported a position in BIIB in Q1 2017 and held it in 4 quarters. The position peaked at $474K in Q1 2017. 1,101 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • ZWJ Investment Counsel reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • ZWJ Investment Counsel sold 1,433 Biogen shares in Q1 2018, an estimated $457K.
  • ZWJ Investment Counsel first reported a position in Biogen in Q1 2017 and held it in 4 quarters.
  • ZWJ Investment Counsel's Biogen position peaked at $474K in Q1 2017.
  • 1,101 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on ZWJ Investment Counsel's 13F filing for Q1 2018, filed 24 Apr 2018.